Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition

SerpinB3 is a serine protease inhibitor that plays a relevant role in disease progression and cancer by increasing fibrosis, cell proliferation, and invasion, besides conferring resistance to apoptosis. The mechanisms underlying these biological activities are not yet fully understood. The aim of this study was to generate antibodies directed against different SerpinB3 epitopes to better investigate their biological role. Five exposed epitopes were identified using the software DNASTAR Lasergene and the corresponding synthetic peptides were used for NZW rabbit immunization. Anti-P#2 and anti-P#4 antibodies were able to recognize both SerpinB3 and SerpinB4 by ELISA. Anti-P#5 antibody, produced against the reactive site loop of SerpinB3, showed the greatest specific reactivity for human SerpinB3. This antibody was able to recognize SerpinB3 at nuclear level, while anti-P#3 antibody recognized SerpinB3 only at cytoplasmic level, both by immunofluorescence and by immunohistochemistry. The biological activity of each antibody preparation was assessed in HepG2 cells overexpressing SerpinB3 and anti-P#5 antibody reduced proliferation by 12% cell and cell invasion by 75%, while trivial results were obtained with the other antibody preparations. These findings indicate that the reactive site loop of SerpinB3 is essential for the invasiveness features induced by this serpin and it could become a novel druggable target.

[1]  P. Pontisso,et al.  Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo , 2022, Pharmaceutics.

[2]  Huange Zhu Squamous Cell Carcinoma Antigen: Clinical Application and Research Status , 2022, Diagnostics.

[3]  Bo Zhang,et al.  PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy. , 2022, Journal of hepatology.

[4]  Jennifer S. Yu,et al.  SerpinB3 drives cancer stem cell survival in glioblastoma , 2021, bioRxiv.

[5]  M. Fassan,et al.  The protease‐inhibitor SerpinB3 as a critical modulator of the stem‐like subset in human cholangiocarcinoma , 2021, Liver international : official journal of the International Association for the Study of the Liver.

[6]  Y. Geng,et al.  Development of a nanobody-based immunoassay for the sensitive detection of fibrinogen-like protein 1 , 2021, Acta Pharmacologica Sinica.

[7]  S. M. Toor,et al.  Immune checkpoints in the tumor microenvironment. , 2020, Seminars in cancer biology.

[8]  J. Marrero,et al.  Biomarkers for the Early Detection of Hepatocellular Carcinoma , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[9]  R. Deshmukh,et al.  Resistance to Checkpoint Inhibition in Cancer Immunotherapy , 2020, Translational oncology.

[10]  M. Rugge,et al.  Squamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity , 2019, Cancer science.

[11]  T. Nakano,et al.  The clinical value of serum squamous cell carcinoma antigens 1 and 2 in head and neck squamous cell carcinoma. , 2019, Auris, nasus, larynx.

[12]  G. Zhu,et al.  Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3 , 2019, Cell.

[13]  Lieping Chen,et al.  A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization , 2018, Cell.

[14]  Rongxin Zhang,et al.  PD-1/PD-L1 pathway blockade works as an effective and practical therapy for cancer immunotherapy , 2018, Cancer biology & medicine.

[15]  P. Pontisso,et al.  SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer , 2017, Oncotarget.

[16]  W. Zong,et al.  SERPINB3 and B4: From biochemistry to biology. , 2017, Seminars in cell & developmental biology.

[17]  M. Rugge,et al.  Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett’s carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy , 2016, Oncotarget.

[18]  J. Wolchok,et al.  Targeting T Cell Co-receptors for Cancer Therapy. , 2016, Immunity.

[19]  P. Pontisso,et al.  Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study. , 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[20]  Haixiang Yu,et al.  Clinical significance of joint detection of serum CEA, SCCA, and bFGF in the diagnosis of lung cancer. , 2015, International journal of clinical and experimental pathology.

[21]  G. Lippi,et al.  Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time? , 2015, Clinica chimica acta; international journal of clinical chemistry.

[22]  P. Pontisso,et al.  SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity , 2015, Scientific Reports.

[23]  X. Wang,et al.  Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches , 2015, Gut.

[24]  T. Yasui,et al.  Prognostic significance of serum squamous cell carcinoma antigen in patients with head and neck cancer , 2015, Acta oto-laryngologica.

[25]  Shi-ling Li,et al.  Overexpression of squamous cell carcinoma antigen 1 is associated with the onset and progression of human hepatocellular carcinoma. , 2015, Archives of medical research.

[26]  W. Zong,et al.  SCCA1/SERPINB3 promotes oncogenesis and epithelial-mesenchymal transition via the unfolded protein response and IL6 signaling. , 2014, Cancer research.

[27]  G. Giannelli,et al.  Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment , 2014, Gut.

[28]  P. Pontisso,et al.  SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis , 2014, British Journal of Cancer.

[29]  W. Zong,et al.  Oncogenic Ras induces inflammatory cytokine production by up-regulating the squamous cell carcinoma antigens SerpinB3/B4 , 2014, Nature Communications.

[30]  P. Pontisso,et al.  SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I , 2013, Oncotarget.

[31]  P. Pontisso,et al.  IgM-Linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease , 2012, PloS one.

[32]  W. Zong,et al.  Squamous Cell Carcinoma Antigen 1 Promotes Caspase-8-Mediated Apoptosis in Response to Endoplasmic Reticulum Stress While Inhibiting Necrosis Induced by Lysosomal Injury , 2011, Molecular and Cellular Biology.

[33]  W. Zong,et al.  Elevated Expression of Squamous Cell Carcinoma Antigen (SCCA) Is Associated with Human Breast Carcinoma , 2011, PloS one.

[34]  P. Pontisso,et al.  Increased antiprotease activity of the SERPINB3 polymorphic variant SCCA-PD , 2011, Experimental biology and medicine.

[35]  P. Pontisso,et al.  SERPINB3 induces epithelial–mesenchymal transition , 2009, The Journal of pathology.

[36]  G. Fields,et al.  Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. , 2009, International journal of peptide and protein research.

[37]  K. Izuhara,et al.  Recent progress in understanding the diversity of the human ov-serpin/clade B serpin family , 2008, Cellular and Molecular Life Sciences.

[38]  T. Oshikiri,et al.  Transcriptional targeting of adenovirus vectors with the squamous cell carcinoma-specific antigen-2 promoter for selective apoptosis induction in lung cancer , 2006, Cancer Gene Therapy.

[39]  Y-F Chen,et al.  Increased expression level of squamous cell carcinoma antigen 2 and 1 ratio is associated with poor prognosis in early-stage uterine cervical cancer , 2006, International Journal of Gynecologic Cancer.

[40]  K. Kadoya,et al.  Serpin squamous cell carcinoma antigen inhibits UV-induced apoptosis via suppression of c-JUN NH2-terminal kinase , 2006, The Journal of cell biology.

[41]  P. Pontisso,et al.  Squamous cell carcinoma antigen‐immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma , 2005, Cancer.

[42]  K. Dewar,et al.  Comparative genomic analysis of the clade B serpin cluster at human chromosome 18q21: amplification within the mouse squamous cell carcinoma antigen gene locus. , 2004, Genomics.

[43]  P. Pontisso,et al.  Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma , 2004, British Journal of Cancer.

[44]  J. Whisstock,et al.  Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis , 2004, Cellular and Molecular Life Sciences CMLS.

[45]  P. Gettins Serpin structure, mechanism, and function. , 2002, Chemical reviews.

[46]  J. Whisstock,et al.  The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases. , 2002, Biochemistry.

[47]  J. Whisstock,et al.  The Serpins Are an Expanding Superfamily of Structurally Similar but Functionally Diverse Proteins , 2001, The Journal of Biological Chemistry.

[48]  L. A. Carpino,et al.  The 5,6- and 4,5-benzo derivatives of 1-hydroxy-7-azabenzotriazole. , 2001, Organic letters.

[49]  H. Hirakawa,et al.  Squamous cell carcinoma antigen suppresses radiation-induced cell death , 2001, British Journal of Cancer.

[50]  S. Pomeroy,et al.  Circulating serpin tumor markers SCCA1 and SCCA2 are not actively secreted but reside in the cytosol of squamous carcinoma cells , 2000, International journal of cancer.

[51]  M. Upton,et al.  Co-expression of the Squamous Cell Carcinoma Antigens 1 and 2 in Normal Adult Human Tissues and Squamous Cell Carcinomas , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[52]  H. Kato,et al.  Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma , 1977, Cancer.

[53]  I. Benhar,et al.  Novel immune check point inhibiting antibodies in cancer therapy-Opportunities and challenges. , 2017, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[54]  Shalini Gupta,et al.  Antibody Production with Synthetic Peptides. , 2016, Methods in molecular biology.

[55]  P. Pontisso,et al.  SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3). , 2015, Atlas of genetics and cytogenetics in oncology and haematology.

[56]  F. Wang,et al.  Squamous cell carcinoma antigen 1 and 2 mRNA and a new variant expressed in hepatocellular carcinoma. , 2014, Neoplasma.

[57]  D. Hancock,et al.  Synthetic peptides as antigens for antibody production. , 2005, Methods in molecular biology.